Aims: Improvement of left ventricular ejection fraction is a major goal of heart failure (HF) treatment. However, data on clinical characteristics, exercise performance and prognosis in HF patients who improved ejection fraction (HFimpEF) are scarce. The study aimed to determine whether HFimpEF patients have a distinct clinical phenotype, biology and prognosis than HF patients with persistently reduced ejection fraction (pHFrEF). Methods and results: 7948 patients enrolled in the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database were evaluated (median follow-up of 1490 days). We analyzed clinical, laboratory, ECG, echocardiographic, exercise, and survival data from HFimpEF (n = 1504) and pHFrEF (n = 6017) patients. The primary endpoint of the study was the composite of cardiovascular death, left ventricular assist device implantation, and urgent heart transplantation. HFimpEF patients had lower HF severity: LVEF 44.0[41.0-47.0] vs. 29.7[24.1-34.5]%, BNP 122[65-296] vs. 373[152-888] pg/mL, hemoglobin 13.5[12.2-14.6] vs. 13.7[12.5-14.7] g/dL, renal function by MDRD 72.0[56.7-89.3] vs. 70.4[54.5-85.3] mL/min, peakVO2 62.2[50.7-74.1] vs. 52.6[41.8-64.3]%pred, VE/VCO2 slope 30.0[26.9-34.4] vs. 32.1[28.0-38.0] in HFimpEF and pHFrEF, respectively (p < 0.001 for all). Cardiovascular mortality rates were 26.6 and 46.9 per 1000 person-years for HFimpEF and pHFrEF, respectively (p < 0.001). Kaplan-Meier analysis showed that HFimpEF had better a long-term prognosis compared with pHFrEF patients. After adjustment for variables differentiating HFimpEF from pHFrEF, except echocardiographic parameters, the Kaplan-Meier curves showed the same prognosis. Conclusions: HFimpEF represents a peculiar group of HF patients whose clinical, laboratory, ECG, echocardiographic, and exercise characteristics parallel the recovery of systolic function. Nonetheless, these patients remain at risk for adverse outcome. This article is protected by copyright. All rights reserved.

Heart failure patients with improved ejection fraction: insights from the MECKI Score database / P. Agostoni, F.R. Pluchinotta, E. Salvioni, M. Mapelli, A. Galotta, A. Bonomi, D. Magrì, E. Perna, S. Paolillo, U. Corrà, R. Raimondo, R. Lagioia, R. Badagliacca, P. Perrone Filardi, A. Apostolo, M. Senni, A. Iorio, M. Correale, J. Campodonico, P. Palermo, M. Cicoira, M. Metra, M. Guazzi, G. Limongelli, M. Contini, B. Pezzuto, G. Sinagra, G. Parati, G. Cattadori, C. Carriere, M. Cittar, M.V. Matassini, A. Salzano, A. Cittadini, M. Masè, F. Bandera, M. Bussotti, I. Mattavelli, F. Re, C. Vignati, C. Lombardi, A.B. Scardovi, S. Sciomer, A. Passantino, M. Emdin, A. Di Lenarda, C. Passino, C. Santolamazza, F. Moscucci, D. Zaffalon, M. Piepoli. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2023). [Epub ahead of print] [10.1002/ejhf.3031]

Heart failure patients with improved ejection fraction: insights from the MECKI Score database

P. Agostoni
Co-primo
;
M. Mapelli;J. Campodonico;M. Guazzi;G. Cattadori;F. Bandera;C. Vignati;M. Piepoli
Ultimo
2023

Abstract

Aims: Improvement of left ventricular ejection fraction is a major goal of heart failure (HF) treatment. However, data on clinical characteristics, exercise performance and prognosis in HF patients who improved ejection fraction (HFimpEF) are scarce. The study aimed to determine whether HFimpEF patients have a distinct clinical phenotype, biology and prognosis than HF patients with persistently reduced ejection fraction (pHFrEF). Methods and results: 7948 patients enrolled in the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database were evaluated (median follow-up of 1490 days). We analyzed clinical, laboratory, ECG, echocardiographic, exercise, and survival data from HFimpEF (n = 1504) and pHFrEF (n = 6017) patients. The primary endpoint of the study was the composite of cardiovascular death, left ventricular assist device implantation, and urgent heart transplantation. HFimpEF patients had lower HF severity: LVEF 44.0[41.0-47.0] vs. 29.7[24.1-34.5]%, BNP 122[65-296] vs. 373[152-888] pg/mL, hemoglobin 13.5[12.2-14.6] vs. 13.7[12.5-14.7] g/dL, renal function by MDRD 72.0[56.7-89.3] vs. 70.4[54.5-85.3] mL/min, peakVO2 62.2[50.7-74.1] vs. 52.6[41.8-64.3]%pred, VE/VCO2 slope 30.0[26.9-34.4] vs. 32.1[28.0-38.0] in HFimpEF and pHFrEF, respectively (p < 0.001 for all). Cardiovascular mortality rates were 26.6 and 46.9 per 1000 person-years for HFimpEF and pHFrEF, respectively (p < 0.001). Kaplan-Meier analysis showed that HFimpEF had better a long-term prognosis compared with pHFrEF patients. After adjustment for variables differentiating HFimpEF from pHFrEF, except echocardiographic parameters, the Kaplan-Meier curves showed the same prognosis. Conclusions: HFimpEF represents a peculiar group of HF patients whose clinical, laboratory, ECG, echocardiographic, and exercise characteristics parallel the recovery of systolic function. Nonetheless, these patients remain at risk for adverse outcome. This article is protected by copyright. All rights reserved.
Heart failure; left ventricular ejection fraction; heart failure with improved ejection fraction; prognosis; outcomes; cardiopulmonary exercise test
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
2023
13-set-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
European J of Heart Fail - 2023 - Agostoni.pdf

embargo fino al 13/09/2024

Descrizione: Article
Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 2.87 MB
Formato Adobe PDF
2.87 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Heart failure.pdf

accesso riservato

Descrizione: online first
Tipologia: Publisher's version/PDF
Dimensione 750.91 kB
Formato Adobe PDF
750.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1001168
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact